MEDICINOVA, INC. Basic Shares Outstanding (Weighted Average)
MEDICINOVA, INC. (MNOV) reported Basic Shares Outstanding (Weighted Average) of 49.22 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- MEDICINOVA, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 49.22M shares, a 0.36% increase year-over-year.
- MEDICINOVA, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 49.22M shares, a 0.36% increase year-over-year.
- MEDICINOVA, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 49.12M shares, a 0.14% increase year-over-year.
- MEDICINOVA, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 49.05M shares, a 0.00% change year-over-year.
- MEDICINOVA, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 49.06M shares, a 0.04% increase from fiscal 2024.
- MEDICINOVA, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 49.05M shares, a 0.00% change from fiscal 2023.
- MEDICINOVA, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 49.05M shares, a 0.00% increase from fiscal 2022.
- MEDICINOVA, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 49.05M shares, a 0.92% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 49.22M shares 10-Q · filed 2026-08-13 | 49.22M shares 10-Q · filed 2026-08-13 | 49.19M shares derived: average of 3 quarters · filed 2026-08-13 | 49.15M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 49.22M shares 10-Q · filed 2026-05-14 | 49.17M shares derived: average of 2 quarters · filed 2026-05-14 | 49.13M shares derived: average of 3 quarters · filed 2026-05-14 | 49.11M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | 49.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 49.08M shares derived: average of 2 quarters · filed 2026-03-10 | 49.07M shares derived: average of 3 quarters · filed 2026-08-13 | 49.06M shares 10-K · filed 2026-03-10 |
| 2025-09-30 | 49.05M shares 10-Q · filed 2025-11-12 | 49.05M shares derived: average of 2 quarters · filed 2026-08-13 | 49.05M shares 10-Q · filed 2025-11-12 | 49.05M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 49.05M shares 10-Q · filed 2026-08-13 | 49.05M shares 10-Q · filed 2026-08-13 | 49.05M shares derived: average of 3 quarters · filed 2026-08-13 | 49.05M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 49.05M shares 10-Q · filed 2026-05-14 | 49.05M shares derived: average of 2 quarters · filed 2026-05-14 | 49.05M shares derived: average of 3 quarters · filed 2026-05-14 | 49.05M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 49.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 49.05M shares derived: average of 2 quarters · filed 2026-03-10 | 49.05M shares derived: average of 3 quarters · filed 2026-03-10 | 49.05M shares 10-K · filed 2026-03-10 |
| 2024-09-30 | 49.05M shares 10-Q · filed 2025-11-12 | 49.05M shares derived: average of 2 quarters · filed 2025-11-12 | 49.05M shares 10-Q · filed 2025-11-12 | 49.05M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 49.05M shares 10-Q · filed 2025-08-14 | 49.05M shares 10-Q · filed 2025-08-14 | 49.05M shares derived: average of 3 quarters · filed 2025-08-14 | 49.05M shares derived: average of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 49.05M shares 10-Q · filed 2025-05-13 | 49.05M shares derived: average of 2 quarters · filed 2025-05-13 | 49.05M shares derived: average of 3 quarters · filed 2025-05-13 | 49.05M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 49.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | 49.05M shares derived: average of 2 quarters · filed 2025-02-19 | 49.05M shares derived: average of 3 quarters · filed 2025-02-19 | 49.05M shares 10-K · filed 2025-02-19 |
| 2023-09-30 | 49.05M shares 10-Q · filed 2024-11-13 | 49.05M shares derived: average of 2 quarters · filed 2024-11-13 | 49.05M shares 10-Q · filed 2024-11-13 | 49.05M shares derived: average of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | 49.05M shares 10-Q · filed 2024-08-08 | 49.05M shares 10-Q · filed 2024-08-08 | 49.05M shares derived: average of 3 quarters · filed 2024-08-08 | 49.05M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 49.05M shares 10-Q · filed 2024-05-09 | 49.05M shares derived: average of 2 quarters · filed 2024-05-09 | 49.05M shares derived: average of 3 quarters · filed 2024-05-09 | 49.05M shares derived: average of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | 49.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | 49.05M shares derived: average of 2 quarters · filed 2024-02-15 | 49.05M shares derived: average of 3 quarters · filed 2024-02-15 | 49.05M shares 10-K · filed 2024-02-15 |
| 2022-09-30 | 49.05M shares 10-Q · filed 2023-11-09 | 49.05M shares derived: average of 2 quarters · filed 2023-11-09 | 49.05M shares 10-Q · filed 2023-11-09 | 49.05M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 49.05M shares 10-Q · filed 2023-08-09 | 49.04M shares 10-Q · filed 2023-08-09 | 49.05M shares derived: average of 3 quarters · filed 2023-08-09 | 49.03M shares derived: average of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | 49.04M shares 10-Q · filed 2023-05-11 | 49.05M shares derived: average of 2 quarters · filed 2023-05-11 | 49.03M shares derived: average of 3 quarters · filed 2023-05-11 | 48.97M shares derived: average of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 49.05M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28 | 49.02M shares derived: average of 2 quarters · filed 2023-03-28 | 48.94M shares derived: average of 3 quarters · filed 2023-03-28 | 48.60M shares 10-K/A · filed 2023-03-28 |
| 2021-09-30 | 48.99M shares 10-Q · filed 2022-11-10 | 48.89M shares derived: average of 2 quarters · filed 2022-11-10 | 48.45M shares 10-Q · filed 2022-11-10 | |
| 2021-06-30 | 48.80M shares 10-Q · filed 2022-08-11 | 48.17M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |